Skip to content

Sunshine Biopharma Inc.

SBFM SBFMW

CIK 0001402328

← back to feed
Revenue (TTM)
$35.82M
+4.1% YoY Q1 May 2026
Net Income (TTM)
−$5.08M
−16.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$46.74
+97.9% YoY Q1 May 2026
Gross Margin
31.8%
Q1 May 2026
Operating Margin
-16.3%
Q1 May 2026
Net Margin
-14.2%
Q1 May 2026
Free Cash Flow (TTM)
−$8.98M
Q1 May 2026
Cash
$19.73M
Q1 May 2026
Total Debt
$2.05M
Q1 May 2026
Shares Outstanding
5.01M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings